Gufic Biosciences Board Meeting on Nov 14 to Approve Unaudited Results

Gufic Biosciences Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for designated persons and their immediate relatives will remain closed until 48 hours after the financial results are declared.